1. P537 Adalimumab: Relevance of drug trough levels and antibodies assessment in the prognosis of Crohn's disease. (16th January 2018) Authors: Perdigoto, D; Macedo, C; Portela, F; Lopes, S; Ferreira, M; Mendes, S; Ferreira, M; Tomé, L Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P720 Is there a difference in trough levels and immunogenicity between Crohn's disease and ulcerative colitis patients treated with infliximab?. (16th January 2018) Authors: Perdigoto, D; Macedo, C; Portela, F; Lopes, S; Ferreira, M; Ferreira, M; Mendes, S; Tomé, L Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗